A detailed history of Bayesian Capital Management, LP transactions in Haleon PLC stock. As of the latest transaction made, Bayesian Capital Management, LP holds 76,000 shares of HLN stock, worth $633,080. This represents 0.06% of its overall portfolio holdings.

Number of Shares
76,000
Holding current value
$633,080
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.02 - $8.67 $609,520 - $658,920
76,000 New
76,000 $645,000
Q1 2023

May 15, 2023

BUY
$7.57 - $8.37 $896,288 - $991,007
118,400 New
118,400 $963,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $38.5B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.